Learn about how Novartis is organized and our strategy, vision and mission. Meet our people and read about our commitments to diversity, equity and inclusion. Explore our history which goes back more than 250 years.
Patients and Caregivers
Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
Research & Development
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Environmental, Social and Governance
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.
Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
Information for journalists including media releases, statements, stories, multimedia resources and more.
Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
Find recruiting clinical trials and learn more about how to participate or work with Novartis on clinical studies. Read about our clinical trials transparency initiatives.
Learn about our approach to partnering which combines capabilities, collaboration and culture.
Practical information and resources for suppliers around the world.
Report side effects
Let us know about any unwanted medical occurrences.
Get in touch.
Welcome to Novartis where we are reimagining medicine to improve and extend people’s lives.
Novartis annual results conference, including media releases and year-to-date figures.
View recent and archived quarterly results.
Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis.
Learn about the fixed-income securities issued by Novartis.
View sales data of the top 20 Innovative Medicines Division products.
Expected currency impact, if currencies stay at mid-September levels in 2023.